文献速递皮肤肿瘤

非黑色素瘤皮肤癌莫氏显微手术患者肿瘤特征与保险类型的关联

Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
PubMed 文献 · JAMA Dermatol · 2022-01-01

这项回顾性队列研究纳入2017年5月至2019年5月在学术型莫氏显微手术(MMS)诊所就诊的1397例非黑色素瘤皮肤癌(NMSC)患者,共1916次MMS手术。与私人保险患者相比,无保险和保险不足患者术前肿瘤床直径和术后缺损尺寸均显著更大(差异均为28%),Medicare和VA保险患者术前肿瘤床直径无显著差异,VA保险患者术后缺损尺寸更大。MMS分期数和闭合类型无显著差异。

要点

  • 无保险和保险不足患者术前肿瘤床直径较私人保险患者大28%(95%CI 14%-43%,P<.001)。
  • 无保险和保险不足患者术后缺损尺寸较私人保险患者大28%(95%CI 16%-41%,P<.001)。
  • VA保险患者术后缺损尺寸较私人保险患者大12%(95%CI 2%-23%,P=.02)。

核心结论

  • 在因NMSC接受MMS的患者中,与私人保险相比,无保险或保险不足与更大的术前肿瘤和术后缺损尺寸相关。
  • 未来需要研究以确定这些差异存在的原因,从而为所有患者提供最佳照护。

研究设计与样本

  • 回顾性队列研究,纳入2017年5月至2019年5月在学术型MMS诊所就诊的NMSC患者1397例,共1916次MMS手术。
  • 患者中978例(70%)为男性,平均(SD)年龄68.5(12.4)岁。
  • 保险类型分布:Medicare 868例(45%),私人保险570例(30%),VA保险299例(16%),安全网诊所或无保险179例(9%)。

主要发现

  • 与私人保险患者相比,无保险和保险不足患者术前肿瘤床直径差异为28%(95%CI 14%-43%,P<.001)。
  • 与私人保险患者相比,无保险和保险不足患者术后缺损尺寸差异为28%(95%CI 16%-41%,P<.001)。
  • Medicare和VA保险患者术前肿瘤床直径与私人保险患者无显著差异。
  • VA保险患者术后缺损尺寸大于私人保险患者,差异为12%(95%CI 2%-23%,P=.02)。
  • MMS分期数和闭合类型按保险类型无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Little is known about the association between insurance type and tumor or treatment characteristics among patients undergoing Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC). OBJECTIVE: To investigate whether there are differences in tumor and treatment characteristics among patients undergoing MMS for NMSC by insurance type. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients with NMSC who presented for surgery at an academic MMS practice between May 2017 and May 2019. MAIN OUTCOMES AND MEASURES: Preoperative and postoperative tumor diameters, number of MMS stages, type of closure, and number of high-risk tumors were compared based on insurance type among uninsured and underinsured patients and those with private insurance, Medicare, and Veterans Affairs (VA) insurance. RESULTS: A total of 1397 patients with NMSC (978 [70%] male; mean [SD] age, 68.5 [12.4] years) underwent 1916 MMS procedures. Of these patients, 868 (45%) had Medicare, 570 (30%) had private insurance, 299 (16%) had VA insurance, and 179 (9%) were treated at a safety net clinic or were uninsured. Compared with patients with private insurance, uninsured and underinsured patients had significantly larger preoperative tumor bed diameters (difference, 28%; 95% CI, 14%-43%; P < .001) and postoperative defect sizes (difference, 28%, 95% CI, 16%-41%; P < .001). Patients with Medicare and VA insurance did not have significantly different preoperative tumor bed diameters compared with patients with private insurance. Patients with VA insurance had larger postoperative defect sizes than patients with private insurance (difference, 12%; 95% CI, 2%-23%; P = .02). The number of MMS stages and type of closure did not significantly differ based on insurance type. CONCLUSIONS AND RELEVANCE: In this cohort study of patients undergoing MMS for NMSC, larger preoperative tumor and postoperative defect sizes were associated with being uninsured or underinsured compared with privately insured. Future studies are required to determine why these differences exist to deliver optimal care to all patients.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Clarke EL, Willenbrink TJ, Shelton M, et al. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer. JAMA Dermatol. 2022. PMID: 35648411. doi:10.1001/jamadermatol.2022.1802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。